ArticleJournal for immunotherapy of cancer2025

Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control.

Maria Del Mar Maldonado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.